Retractable Technologies, Inc. ("Retractable") (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B ...

Sanofi's subcutaneous formulation of multiple myeloma drug Sarclisa has been approved in the UK, which will be the first market for the on-body injector (OBI) version of the drug.

While the Meta-owned social network billed Instants as a new format to share real-life moments as they’re happening, many users are looking for a way  to turn off the feature, especially those who ...

CLAIM: Video shows health care worker faking giving the COVID-19 vaccine in England with a “disappearing needle.” THE FACTS: The video does not show a staged shot. As video footage of COVID-19 ...

Testing companies have revealed little about how their products perform in minors. That could be a problem. By Katherine J. Wu The reversal came just hours after the federal government threatened the ...

Retractable Technologies, the maker of a retractable needle and other safety medical products, is cutting roughly 16% of its workforce in a cost-saving move to reduce overhead by $2.2 million a year ...

Retractable Technologies, Inc. (NYSE American: RVP) reports the following information relating to the year ended December 31, 2025. Further details concerning the results of operations as well as ...

LITTLE ELM, Texas, March 27, 2026--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports the following information relating to the year ended December 31, 2025. Further details ...

CHICAGO, IL, UNITED STATES, February 12, 2026 /EINPresswire.com/ — CCPA Purchasing Partners, LLC (CCPAPP) is excited to announce a new Premier contract offering ...